Breakthrough bone cancer drug slows tumor growth, extends survival in early studies

2 years ago 32

For those suffering from primary bone cancer, a promising new medication called CADD522 may be on the horizon. In early tests, it extended survival and reduced tumor growth.

1. Homepage
2. Health
3. Breakthrough bone cancer drug slows tumor growth, extends survival in early studies